Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
CNS & neurological disorders drug targets
| CNS & neurological disorders drug targets |
| Pubbl/distr/stampa | Saif Zone, Sharjah, U.A.E. ; ; San Francisco, CA, : Bentham Science Publishers, ©2006- |
| Descrizione fisica | 1 online resource |
| Soggetto topico |
Neuropharmacology
Nervous system - Diseases - Effect of drugs on Drug delivery systems Drugs - Design Central Nervous System Diseases - drug therapy Nervous System Diseases - drug therapy Drug Delivery Systems Drug Design |
| Soggetto genere / forma | Periodicals. |
| ISSN | 1996-3181 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Altri titoli varianti |
CNS & neurological disorders. Drug targets
CNS and neurological disorders drug targets |
| Record Nr. | UNISA-996207246403316 |
| Saif Zone, Sharjah, U.A.E. ; ; San Francisco, CA, : Bentham Science Publishers, ©2006- | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Comprehensive quality by design for pharmaceutical product development and manufacture / / edited by Gintaras V. Reklaitis, Salvador Garcia-Munoz, Christine Seymour
| Comprehensive quality by design for pharmaceutical product development and manufacture / / edited by Gintaras V. Reklaitis, Salvador Garcia-Munoz, Christine Seymour |
| Pubbl/distr/stampa | Hoboken, New Jersey : , : Wiley, , 2017 |
| Descrizione fisica | 1 online resource (397 pages) |
| Disciplina | 615.1/9 |
| Soggetto topico |
Drugs - Design
Pharmaceutical technology - Quality control |
| ISBN |
1-119-35617-2
1-119-35616-4 1-119-35618-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910270939003321 |
| Hoboken, New Jersey : , : Wiley, , 2017 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Comprehensive quality by design for pharmaceutical product development and manufacture / / edited by Gintaras V. Reklaitis, Salvador Garcia-Munoz, Christine Seymour
| Comprehensive quality by design for pharmaceutical product development and manufacture / / edited by Gintaras V. Reklaitis, Salvador Garcia-Munoz, Christine Seymour |
| Pubbl/distr/stampa | Hoboken, New Jersey : , : Wiley, , 2017 |
| Descrizione fisica | 1 online resource (397 pages) |
| Disciplina | 615.1/9 |
| Soggetto topico |
Drugs - Design
Pharmaceutical technology - Quality control |
| ISBN |
1-119-35617-2
1-119-35616-4 1-119-35618-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910811302803321 |
| Hoboken, New Jersey : , : Wiley, , 2017 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Computational pharmaceutics : application of molecular modeling in drug delivery / / edited by Defang Ouyang and Sean C. Smith
| Computational pharmaceutics : application of molecular modeling in drug delivery / / edited by Defang Ouyang and Sean C. Smith |
| Pubbl/distr/stampa | Chichester, [England] : , : Wiley, , 2015 |
| Descrizione fisica | 1 online resource (336 p.) |
| Disciplina | 615.6 |
| Collana | Advances in Pharmaceutical Technology |
| Soggetto topico |
Drug delivery systems
Computational biology Drugs - Design |
| ISBN |
1-118-57397-8
1-118-57398-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Introduction of computational pharmaceutics / Ouyang -- Crystal energy landscapes for aiding crystal form selection / Sarah Price -- Solubilization of poor-soluble drugs in cyclodextron formulation / Ouyang -- Molecular modeling for polymeric and micellar drug delivery / Sharon M.Loverde -- Solid dispersion : a pragmatic method to improve the bioavailability of poorly soluble drugs / Ouyang -- Computer simulations of lipid membranes and liposomes for drug delivery / Becky Notman -- Molecular modeling for protein aggregation and formulation / Jim Warwicker -- Computational simulation of drug delivery by nano-materials at molecular level / Youyong Li -- Molecular and analytical modeling of nanodiamond for drug delivery applications / Amanda Barnard -- Molecular modeling of LDH drug delivery systems / Vinuthaa Murthy -- Molecular dynamics simulation as a tool to study the efficacy of PEGylation / Alex Bunker -- Synchrotron radiation micro computed tomography : a new approach for quantitative 3D structural architecture of drug delivery systems / Jiwen Zhang -- Pharmacokinetic modelling and simulation in drug delivery / Raj. |
| Record Nr. | UNINA-9910140638503321 |
| Chichester, [England] : , : Wiley, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Computational pharmaceutics : application of molecular modeling in drug delivery / / edited by Defang Ouyang and Sean C. Smith
| Computational pharmaceutics : application of molecular modeling in drug delivery / / edited by Defang Ouyang and Sean C. Smith |
| Pubbl/distr/stampa | Chichester, [England] : , : Wiley, , 2015 |
| Descrizione fisica | 1 online resource (336 p.) |
| Disciplina | 615.6 |
| Collana | Advances in Pharmaceutical Technology |
| Soggetto topico |
Drug delivery systems
Computational biology Drugs - Design |
| ISBN |
1-118-57397-8
1-118-57398-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Introduction of computational pharmaceutics / Ouyang -- Crystal energy landscapes for aiding crystal form selection / Sarah Price -- Solubilization of poor-soluble drugs in cyclodextron formulation / Ouyang -- Molecular modeling for polymeric and micellar drug delivery / Sharon M.Loverde -- Solid dispersion : a pragmatic method to improve the bioavailability of poorly soluble drugs / Ouyang -- Computer simulations of lipid membranes and liposomes for drug delivery / Becky Notman -- Molecular modeling for protein aggregation and formulation / Jim Warwicker -- Computational simulation of drug delivery by nano-materials at molecular level / Youyong Li -- Molecular and analytical modeling of nanodiamond for drug delivery applications / Amanda Barnard -- Molecular modeling of LDH drug delivery systems / Vinuthaa Murthy -- Molecular dynamics simulation as a tool to study the efficacy of PEGylation / Alex Bunker -- Synchrotron radiation micro computed tomography : a new approach for quantitative 3D structural architecture of drug delivery systems / Jiwen Zhang -- Pharmacokinetic modelling and simulation in drug delivery / Raj. |
| Record Nr. | UNINA-9910824189203321 |
| Chichester, [England] : , : Wiley, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Contemporary drug synthesis / / Jie Jack Li [et al.]
| Contemporary drug synthesis / / Jie Jack Li [et al.] |
| Pubbl/distr/stampa | Hoboken, N.J. : , : Wiley-Interscience, , 2004 |
| Descrizione fisica | 1 online resource (xv, 221 pages) : illustrations |
| Disciplina | 615/.31 |
| Altri autori (Persone) | LiJie Jack |
| Soggetto topico |
Pharmaceutical chemistry
Drugs - Design |
| ISBN |
1-280-27291-0
9786610272914 0-470-23708-2 0-471-68673-5 0-471-68674-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Contemporary Drug Synthesis; Preface; Table of Contents; Trade Names and Their Corresponding USANs; Acronyms and Abbreviations; Chapter 1: Antithrombotics: Ticlopidine (Ticlid® and Clopidogrel (Plavix®); 1 .1 Introduction; 1.2 Syntheses of ticlopidine; 1.3 Syntheses of clopidogrel; 1.4 References; Chapter 2. Anti-inflammatory Cyclooxygenase-2 Selective Inhibitors: Celecoxib (Celebrex®) and Rofecoxib (Vioxx®); 2.1 Introduction; 2.2 Synthesis of celecoxib; 2.3 Syntheses of rofecoxib; 2.4 References; Chapter 3. H+/K+-ATPase Inhibitors: Esomeprazole (Nexium®); 3.1 Introduction
3.2 Synthesis of esomeprazole; 3.2.1 Separation using HPLC; 3.2.2 Asymmetric oxidation of the sulfide; 3.2.3 Biooxidation; 3.3 References; Chapter 4. Protein-tyrosine Kinase Inhibitors: Imatinib (Gleevec®) and Gefitinib (Iressa®); 4.1 Introduction to Gleevec®; 4.2 Synthesis of imatinib mesylate; 4.3 Introduction to Iressa®; 4.4 Synthesis of gefitinib; 4.5 References; Chapter 5. Non-sedating Antihistamines; 5.1 Introduction; 5.2 Synthesis of loratadine and desloratadine; 5.3 Synthesis of fexofenadine; 5.4 Synthesis of cetirizine; 5.5 References Chapter 6. Cosmeceuticals: Isotretinoin (Accutane®), Tazarotene (Tazorac®), Minoxidil (Rogaine®), and Finasteride (Propecia®); 6.1 Isotretinoin; 6.1.1 Introduction to isotretinoin; 6.1.2 Synthesis of isotretinoin; 6.2 Tazarotene; 6.2.1 Introduction to tazarotene; 6.2.2 Synthesis of tazarotene; 6.3 Minoxidil; 6.3.1 Introduction to minoxidil; 6.3.2 Synthesis of minoxidil; 6.4 Finasteride; 6.4.1 Introduction to finasteride; 6.4.2 Synthesis of finasteride; 6.5 References; Chapter 7. Antibacterials: Ciprofloxacin (Cipro®) and Linezolid (Zyvox®); 7.1 Ciprofloxacin (Cipro®) 7.1.1 Introduction to ciprofloxacin 7.1.2 Synthesis of ciprofloxacin; 7.2 Linezolid (Zyvox®); 7.2.1 Introduction to linezolid; 7.2.2 Synthesis of linezolid; 7.3 References; Chapter 8. Atypical Antipsychotics; 8.1 Introduction; 8.2 Synthesis of risperidone; 8.3 Synthesis of olanzapine; 8.4 Synthesis of quetiapine fumarate; 8.5 Synthesis of ziprasidone; 8.6 Synthesis of aripiprazole; 8.7 References; Chapter 9. Atorvastatin Calcium (Lipitor®); 9.1 Background; 9.2 Synthesis of racemic atorvastatin; 9.3 Enantioselective syntheses of atorvastatin calcium; 9.4 References Chapter 10. Antidepressants; 10.1 Background; 10.2 Synthesis of fluoxetine hydrochloride; 10.3 Synthesis of sertraline hydrochloride; 10.4 Synthesis of paroxetine hydrochloride; 10.5 References; Chapter 11. Anti-obesity: Orlistat (Xenical®); 11.1 Introduction; 11.2 Synthesis of orlistat; 11.3 References; Chapter 12. Triptans for Migraine; 12.1 Introduction; 12.2 Synthesis of sumatriptan; 12.3 Synthesis of zolmitriptan; 12.4 Synthesis of naratriptan; 12.5 Synthesis of rizatriptan; 12.6 Synthesis of almotriptan; 12.7 Synthesis of frovatriptan; 12.8 Synthesis of eletriptan; 12.9 References |
| Record Nr. | UNINA-9910146084303321 |
| Hoboken, N.J. : , : Wiley-Interscience, , 2004 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Contemporary drug synthesis / / Jie Jack Li [et al.]
| Contemporary drug synthesis / / Jie Jack Li [et al.] |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Hoboken, N.J. : , : Wiley-Interscience, , 2004 |
| Descrizione fisica | 1 online resource (xv, 221 pages) : illustrations |
| Disciplina | 615/.31 |
| Altri autori (Persone) | LiJie Jack |
| Soggetto topico |
Pharmaceutical chemistry
Drugs - Design |
| ISBN |
1-280-27291-0
9786610272914 0-470-23708-2 0-471-68673-5 0-471-68674-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Contemporary Drug Synthesis; Preface; Table of Contents; Trade Names and Their Corresponding USANs; Acronyms and Abbreviations; Chapter 1: Antithrombotics: Ticlopidine (Ticlid® and Clopidogrel (Plavix®); 1 .1 Introduction; 1.2 Syntheses of ticlopidine; 1.3 Syntheses of clopidogrel; 1.4 References; Chapter 2. Anti-inflammatory Cyclooxygenase-2 Selective Inhibitors: Celecoxib (Celebrex®) and Rofecoxib (Vioxx®); 2.1 Introduction; 2.2 Synthesis of celecoxib; 2.3 Syntheses of rofecoxib; 2.4 References; Chapter 3. H+/K+-ATPase Inhibitors: Esomeprazole (Nexium®); 3.1 Introduction
3.2 Synthesis of esomeprazole; 3.2.1 Separation using HPLC; 3.2.2 Asymmetric oxidation of the sulfide; 3.2.3 Biooxidation; 3.3 References; Chapter 4. Protein-tyrosine Kinase Inhibitors: Imatinib (Gleevec®) and Gefitinib (Iressa®); 4.1 Introduction to Gleevec®; 4.2 Synthesis of imatinib mesylate; 4.3 Introduction to Iressa®; 4.4 Synthesis of gefitinib; 4.5 References; Chapter 5. Non-sedating Antihistamines; 5.1 Introduction; 5.2 Synthesis of loratadine and desloratadine; 5.3 Synthesis of fexofenadine; 5.4 Synthesis of cetirizine; 5.5 References Chapter 6. Cosmeceuticals: Isotretinoin (Accutane®), Tazarotene (Tazorac®), Minoxidil (Rogaine®), and Finasteride (Propecia®); 6.1 Isotretinoin; 6.1.1 Introduction to isotretinoin; 6.1.2 Synthesis of isotretinoin; 6.2 Tazarotene; 6.2.1 Introduction to tazarotene; 6.2.2 Synthesis of tazarotene; 6.3 Minoxidil; 6.3.1 Introduction to minoxidil; 6.3.2 Synthesis of minoxidil; 6.4 Finasteride; 6.4.1 Introduction to finasteride; 6.4.2 Synthesis of finasteride; 6.5 References; Chapter 7. Antibacterials: Ciprofloxacin (Cipro®) and Linezolid (Zyvox®); 7.1 Ciprofloxacin (Cipro®) 7.1.1 Introduction to ciprofloxacin 7.1.2 Synthesis of ciprofloxacin; 7.2 Linezolid (Zyvox®); 7.2.1 Introduction to linezolid; 7.2.2 Synthesis of linezolid; 7.3 References; Chapter 8. Atypical Antipsychotics; 8.1 Introduction; 8.2 Synthesis of risperidone; 8.3 Synthesis of olanzapine; 8.4 Synthesis of quetiapine fumarate; 8.5 Synthesis of ziprasidone; 8.6 Synthesis of aripiprazole; 8.7 References; Chapter 9. Atorvastatin Calcium (Lipitor®); 9.1 Background; 9.2 Synthesis of racemic atorvastatin; 9.3 Enantioselective syntheses of atorvastatin calcium; 9.4 References Chapter 10. Antidepressants; 10.1 Background; 10.2 Synthesis of fluoxetine hydrochloride; 10.3 Synthesis of sertraline hydrochloride; 10.4 Synthesis of paroxetine hydrochloride; 10.5 References; Chapter 11. Anti-obesity: Orlistat (Xenical®); 11.1 Introduction; 11.2 Synthesis of orlistat; 11.3 References; Chapter 12. Triptans for Migraine; 12.1 Introduction; 12.2 Synthesis of sumatriptan; 12.3 Synthesis of zolmitriptan; 12.4 Synthesis of naratriptan; 12.5 Synthesis of rizatriptan; 12.6 Synthesis of almotriptan; 12.7 Synthesis of frovatriptan; 12.8 Synthesis of eletriptan; 12.9 References |
| Record Nr. | UNINA-9910818441403321 |
| Hoboken, N.J. : , : Wiley-Interscience, , 2004 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Contemporary drug synthesis / / Jie Jack Li [et al.]
| Contemporary drug synthesis / / Jie Jack Li [et al.] |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Hoboken, N.J. : , : Wiley-Interscience, , 2004 |
| Descrizione fisica | 1 online resource (xv, 221 pages) : illustrations |
| Disciplina | 615/.31 |
| Altri autori (Persone) | LiJie Jack |
| Soggetto topico |
Pharmaceutical chemistry
Drugs - Design |
| ISBN |
1-280-27291-0
9786610272914 0-470-23708-2 0-471-68673-5 0-471-68674-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Contemporary Drug Synthesis; Preface; Table of Contents; Trade Names and Their Corresponding USANs; Acronyms and Abbreviations; Chapter 1: Antithrombotics: Ticlopidine (Ticlid® and Clopidogrel (Plavix®); 1 .1 Introduction; 1.2 Syntheses of ticlopidine; 1.3 Syntheses of clopidogrel; 1.4 References; Chapter 2. Anti-inflammatory Cyclooxygenase-2 Selective Inhibitors: Celecoxib (Celebrex®) and Rofecoxib (Vioxx®); 2.1 Introduction; 2.2 Synthesis of celecoxib; 2.3 Syntheses of rofecoxib; 2.4 References; Chapter 3. H+/K+-ATPase Inhibitors: Esomeprazole (Nexium®); 3.1 Introduction
3.2 Synthesis of esomeprazole; 3.2.1 Separation using HPLC; 3.2.2 Asymmetric oxidation of the sulfide; 3.2.3 Biooxidation; 3.3 References; Chapter 4. Protein-tyrosine Kinase Inhibitors: Imatinib (Gleevec®) and Gefitinib (Iressa®); 4.1 Introduction to Gleevec®; 4.2 Synthesis of imatinib mesylate; 4.3 Introduction to Iressa®; 4.4 Synthesis of gefitinib; 4.5 References; Chapter 5. Non-sedating Antihistamines; 5.1 Introduction; 5.2 Synthesis of loratadine and desloratadine; 5.3 Synthesis of fexofenadine; 5.4 Synthesis of cetirizine; 5.5 References Chapter 6. Cosmeceuticals: Isotretinoin (Accutane®), Tazarotene (Tazorac®), Minoxidil (Rogaine®), and Finasteride (Propecia®); 6.1 Isotretinoin; 6.1.1 Introduction to isotretinoin; 6.1.2 Synthesis of isotretinoin; 6.2 Tazarotene; 6.2.1 Introduction to tazarotene; 6.2.2 Synthesis of tazarotene; 6.3 Minoxidil; 6.3.1 Introduction to minoxidil; 6.3.2 Synthesis of minoxidil; 6.4 Finasteride; 6.4.1 Introduction to finasteride; 6.4.2 Synthesis of finasteride; 6.5 References; Chapter 7. Antibacterials: Ciprofloxacin (Cipro®) and Linezolid (Zyvox®); 7.1 Ciprofloxacin (Cipro®) 7.1.1 Introduction to ciprofloxacin 7.1.2 Synthesis of ciprofloxacin; 7.2 Linezolid (Zyvox®); 7.2.1 Introduction to linezolid; 7.2.2 Synthesis of linezolid; 7.3 References; Chapter 8. Atypical Antipsychotics; 8.1 Introduction; 8.2 Synthesis of risperidone; 8.3 Synthesis of olanzapine; 8.4 Synthesis of quetiapine fumarate; 8.5 Synthesis of ziprasidone; 8.6 Synthesis of aripiprazole; 8.7 References; Chapter 9. Atorvastatin Calcium (Lipitor®); 9.1 Background; 9.2 Synthesis of racemic atorvastatin; 9.3 Enantioselective syntheses of atorvastatin calcium; 9.4 References Chapter 10. Antidepressants; 10.1 Background; 10.2 Synthesis of fluoxetine hydrochloride; 10.3 Synthesis of sertraline hydrochloride; 10.4 Synthesis of paroxetine hydrochloride; 10.5 References; Chapter 11. Anti-obesity: Orlistat (Xenical®); 11.1 Introduction; 11.2 Synthesis of orlistat; 11.3 References; Chapter 12. Triptans for Migraine; 12.1 Introduction; 12.2 Synthesis of sumatriptan; 12.3 Synthesis of zolmitriptan; 12.4 Synthesis of naratriptan; 12.5 Synthesis of rizatriptan; 12.6 Synthesis of almotriptan; 12.7 Synthesis of frovatriptan; 12.8 Synthesis of eletriptan; 12.9 References |
| Record Nr. | UNISA-996211665003316 |
| Hoboken, N.J. : , : Wiley-Interscience, , 2004 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Current drug synthesis / / Jie Jack Li
| Current drug synthesis / / Jie Jack Li |
| Autore | Li Jie Jack |
| Pubbl/distr/stampa | Hoboken, New Jersey : , : John Wiley & Sons, Inc., , [2022] |
| Descrizione fisica | 1 online resource (402 pages) |
| Disciplina | 615.19 |
| Collana | Wiley Series on Drug Synthesis Ser. |
| Soggetto topico |
Drugs - Design
Pharmaceutical chemistry |
| ISBN |
1-119-84728-1
1-119-84726-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910643162903321 |
Li Jie Jack
|
||
| Hoboken, New Jersey : , : John Wiley & Sons, Inc., , [2022] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Current drug synthesis / / Jie Jack Li
| Current drug synthesis / / Jie Jack Li |
| Autore | Li Jie Jack |
| Pubbl/distr/stampa | Hoboken, New Jersey : , : John Wiley & Sons, Inc., , [2022] |
| Descrizione fisica | 1 online resource (402 pages) |
| Disciplina | 615.19 |
| Collana | Wiley Series on Drug Synthesis |
| Soggetto topico |
Drugs - Design
Pharmaceutical chemistry |
| ISBN |
1-119-84728-1
1-119-84726-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910830204803321 |
|
Li Jie Jack
|
||
| Hoboken, New Jersey : , : John Wiley & Sons, Inc., , [2022] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Soggetto topico
-
Drugs - Design
(307)
- Pharmaceutical chemistry (91)
- Drug development (68)
- Drug Design (35)
- Biopharmaceutics (16)